October 21, 2014

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.

 

October 20, 2014

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 16, 2014

Specialty pharmacy Burmans last week received the new “Shaping Healthcare Delivery” award at this year’s AmerisourceBergen’s ThinkLive Conference. 

October 10, 2014

The Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission on Wednesday announced the completion of a new, $13 million molecular imaging pharmaceuticals center.

October 10, 2014

Shares of Diplomat Pharmacy officially began trading on Friday at a price that had reached more than $17 per share in mid-afternoon trading.

 

October 9, 2014

Catamaran, a provider of technology and pharmacy benefit management services, on Wednesday announced that it has entered into a definitive agreement to acquire Salveo Specialty Pharmacy.

October 8, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

October 8, 2014

Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. 

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

October 6, 2014

Specialty drug spending continues to rise and is predicted to grow by more than 16% annually from 2015 to 2018. CVS Health researchers examine the reasons for such dramatic increases in spending and discuss tools to help manage these escalating costs.

October 6, 2014

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

October 3, 2014

In celebration of all that they do, October is designated as American Pharmacists Month. Drug Store News wants to hear from you! Have you had a pharmacist that went above and beyond to help?

October 1, 2014

October is recognized as American Pharmacists Month and the American Pharmacists Association wants to send a clear message: “Know Your Pharmacist—Know Your Medicine.”

October 1, 2014

Diplomat on Tuesday announced that Stephen Brown has been named chief information officer.

September 29, 2014

Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.

September 29, 2014

Diplomat Pharmacy on Monday announced that it has commenced its initial public offering of 13.3 million shares of its common stock.

 

September 29, 2014

Health experts argue that there are tactics that payers and purchasers can deploy to help improve patient access.

September 29, 2014

According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.

September 26, 2014

Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2.

September 25, 2014

Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.

September 24, 2014

Want satisfied pharmacy customers? Ensure that they have direct interaction and collaboration with pharmacists and implement an in-store clinic or wellness center. 

 

September 16, 2014

Lupin has entered into a long-term partnership with Merck Serono for the implementation of the company's general medicines portfolio expansion initiative in emerging markets, helping to fulfill local needs for affordable medications.